“There must be a good assessment of these markers”

esanum-interview with Prof. Dr. Anna Sapino, Department of Medical Sciences, University of Turin (Italy), on the clinical relevance of markers in breast cancer besides grade and stage.

esanum-interview with Prof. Dr. Anna Sapino, Department of Medical Sciences, University of Turin (Italy), on the clinical relevance of markers in breast cancer besides grade and stage.

Are Tumor-Infiltrating Lymphoctes (TILs) a new marker in breast cancer? “Not really new”, says Prof. Anna Sapino (Italy), “but it was something we didn’t care about before. Now we know it is important that we see it  and report it to the oncologist, because it may guide prognosis and prediction of response to chemotherapy.” The Italian pathologist also shortly comments on some other markers of clinical relevance. She chairs the ESP breast working group and appreciated the cooperation with her IAP colleagues in order to prepare for the first joint congress of the societies.